Notifications
Back


TriOar is writing a story that will become a legend.



TriOar is pioneering an innovative path that no one else has ever walked.

TriOar is writing a story that will become a legend.


TriOar is pioneering an innovative path that no one else has ever walked.



R&D

Better Ideas ∙ Better Technologies ∙ Better Therapeutics.

TriOar is shaping a better, healthier future for those in need.  

Insight · Faith · Resilience

TriOar is leading the therapeutics industry, unlocking new possibilities based on its core values.










OAR 1

Tumor Navigator
Tumor Micro Environment










OAR 2

Tumor Target
Druggable &Novel










OAR 3

Tumor Killer
Novel SIG system

PIPELINE
Both development time and costs are improved due to increased efficacy and reduced toxicity.

Our new target drug and novel drug format not only satisfy unmet medical needs but also introduce new treatment options.

CORE TECHNOLOGY

Our novel medicines with innovative technologies bring new yet promising options to patients.

Excellent research infrastructure

World-class R&D infrastructure backed by excellent domestic and foreign experts.

Proprietary core technologies and platforms

Insight and differentiated technologies acquired through years of experience.

A clear strategy for novel antibody drug development

Prudent new drug development approach based on sophisticated plans and focused strategy

Diverse partnerships

Build diverse partnerships. 


NEWS

 TriOar is shaping a better, healthier future for those in need.

You do not have permission.
Sign in with an authorized account.

CEO : Woo Seongho  ㅣ Business License : 302-86-01952
Head office  ㅣ 39th and 2nd floors, Techno 4-ro, Yuseong-gu, Daejeon. 

Tel. 042-931-3911ㅣ Fax. 042-933-3912

E-mail. trioar@trioar.co.kr

Copyright ⓒ TRIOAR. ALL rights reserved.


Hosting by ALLONECARE